UB Paderborn / Katalog / Suche / in CDI

1 – 22 von 22

Sortiert nach

Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand

The New England journal of medicine, 2009-12, Vol.361 (23), p.2209-2220

2009

Volltextzugriff (PDF)

OA04-06 LB. Post-infection cellular immune responses in recipients following ALVAC-HIV® + AIDSVAX® B/E prime-boost vaccination in the Thai Phase III Trial

Retrovirology, 2009-10, Vol.6 (S3), p.O30-O30, Article O30

2009

Volltextzugriff (PDF)

OA07-04 LB. Immunogenicity of ALVAC-HIV® (vCP1521) and AIDSVAX® B/E prime boose vaccination in RV144, the Thai Phase III HIV vaccine trial

Retrovirology, 2009-10, Vol.6 (S3), p.O52-O52, Article O52

2009

Volltextzugriff (PDF)

Incidence and characterization of acute HIV-1 infection in a high-risk Thai population

Journal of acquired immune deficiency syndromes (1999), 2008-10, Vol.49 (2), p.151

2008

Volltextzugriff (PDF)

HLA class II restriction of HIV-1 clade-specific neutralizing antibody responses in ethnic Thai recipients of the RV144 prime-boost vaccine combination of ALVAC-HIV and AIDSVAX® B/E

Vaccine, 2012-01, Vol.30 (5), p.832-836

2012

Volltextzugriff (PDF)

Application of Dried Blood Spot Specimens for Serologic Subtyping of Human Immunodeficiency Virus Type 1 in Thailand

Journal of Clinical Microbiology, 1999-03, Vol.37 (3), p.804-806

1999

Volltextzugriff (PDF)

Comparative analysis of HIV-1 viral load assays on subtype quantification: Bayer Versant HIV-1 RNA 3.0 versus Roche Amplicor HIV-1 Monitor version 1.5

Journal of acquired immune deficiency syndromes (1999), 2002-04, Vol.29 (4), p.330

2002

Volltextzugriff (PDF)

Detection and quantification of HIV type 1 RNA in nasopharyngeal washes from HIV-infected subjects

AIDS research and human retroviruses, 2001-02, Vol.17 (3), p.229-232

2001

Volltextzugriff (PDF)

First CRF01―AE/B recombinant of HIV-1 is found in Thailand

AIDS (London), 2001-05, Vol.15 (8), p.1063-1065

2001

Volltextzugriff (PDF)

Heterosexually acquired CRF01―AE/B recombinant HIV type 1 found in Thailand

AIDS research and human retroviruses, 2002-11, Vol.18 (16), p.1235-1237

2002

Volltextzugriff (PDF)

HIV viral load in Thai men and women with subtype E infections

Journal of acquired immune deficiency syndromes (1999), 2001-04, Vol.26 (4), p.345

2001

Volltextzugriff (PDF)

OA07-04 LB. Immunogenicity of ALVAC-HIVRG (vCP1521) and AIDSVAXRG B/E prime boose vaccination in RV144, the Thai Phase III HIV vaccine trial

Retrovirology, 2009-01, Vol.6 (Suppl 3), p.O52-O52

2009

Volltextzugriff (PDF)

OA04-06 LB. Post-infection cellular immune responses in recipients following ALVAC-HIVRG + AIDSVAXRG B/E prime-boost vaccination in the Thai Phase III Trial

Retrovirology, 2009-01, Vol.6 (Suppl 3), p.O30-O30

2009

Volltextzugriff (PDF)

Correlation of genetic and serologic approaches to HIV-1 subtyping in Thailand

Journal of acquired immune deficiency syndromes and human retrovirology, 1996-12, Vol.13 (4), p.392

1996

Volltextzugriff (PDF)

Prospective Study of Acute HIV-1 Infection in Adults in East Africa and Thailand

The New England journal of medicine, 2016-06, Vol.374 (22), p.2120-2130

2016

Volltextzugriff (PDF)

The Thai Phase III HIV Type 1 Vaccine trial (RV144) regimen induces antibodies that target conserved regions within the V2 loop of gp120

AIDS research and human retroviruses, 2012-11, Vol.28 (11), p.1444

2012

Volltextzugriff (PDF)

Plasmacytoid dendritic cells sense HIV replication before detectable viremia following treatment interruption

The Journal of clinical investigation, 2020-06, Vol.130 (6), p.2845-2858

2020

Volltextzugriff (PDF)

Safety and efficacy of VRC01 broadly neutralising antibodies in adults with acutely treated HIV (RV397): a phase 2, randomised, double-blind, placebo-controlled trial

The lancet HIV, 2019-05, Vol.6 (5), p.e297-e306

2019

Volltextzugriff (PDF)

Preferential Infection of α4β7+ Memory CD4+ T Cells During Early Acute Human Immunodeficiency Virus Type 1 Infection

Clinical infectious diseases, 2020-12, Vol.71 (11), p.e735-e743

2020

Volltextzugriff (PDF)

The Thai phase III trial (RV144) vaccine regimen induces T cell responses that preferentially target epitopes within the V2 region of HIV-1 envelope

The Journal of immunology (1950), 2012-05, Vol.188 (10), p.5166-5176

2012

Volltextzugriff (PDF)

Impact of Early Antiretroviral Therapy on Detection of Cell-Associated HIV-1 Nucleic Acid in Blood by the Roche Cobas TaqMan Test

Journal of clinical microbiology, 2019-05, Vol.57 (5)

2019

Volltextzugriff (PDF)

1 – 22 von 22

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(16)

Publikationsform

Artikel
(22)

Sprache

Englisch
(22)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand

OA04-06 LB. Post-infection cellular immune responses in recipients following ALVAC-HIV® + AIDSVAX® B/E prime-boost vaccination in the Thai Phase III Trial

OA07-04 LB. Immunogenicity of ALVAC-HIV® (vCP1521) and AIDSVAX® B/E prime boose vaccination in RV144, the Thai Phase III HIV vaccine trial

Incidence and characterization of acute HIV-1 infection in a high-risk Thai population

HLA class II restriction of HIV-1 clade-specific neutralizing antibody responses in ethnic Thai recipients of the RV144 prime-boost vaccine combination of ALVAC-HIV and AIDSVAX® B/E

Application of Dried Blood Spot Specimens for Serologic Subtyping of Human Immunodeficiency Virus Type 1 in Thailand

Comparative analysis of HIV-1 viral load assays on subtype quantification: Bayer Versant HIV-1 RNA 3.0 versus Roche Amplicor HIV-1 Monitor version 1.5

Detection and quantification of HIV type 1 RNA in nasopharyngeal washes from HIV-infected subjects

First CRF01―AE/B recombinant of HIV-1 is found in Thailand

Heterosexually acquired CRF01―AE/B recombinant HIV type 1 found in Thailand

HIV viral load in Thai men and women with subtype E infections

OA07-04 LB. Immunogenicity of ALVAC-HIVRG (vCP1521) and AIDSVAXRG B/E prime boose vaccination in RV144, the Thai Phase III HIV vaccine trial

OA04-06 LB. Post-infection cellular immune responses in recipients following ALVAC-HIVRG + AIDSVAXRG B/E prime-boost vaccination in the Thai Phase III Trial

Correlation of genetic and serologic approaches to HIV-1 subtyping in Thailand

Rapid HIV RNA rebound after antiretroviral treatment interruption in persons durably suppressed in Fiebig I acute HIV infection

Prospective Study of Acute HIV-1 Infection in Adults in East Africa and Thailand

The Thai Phase III HIV Type 1 Vaccine trial (RV144) regimen induces antibodies that target conserved regions within the V2 loop of gp120

Plasmacytoid dendritic cells sense HIV replication before detectable viremia following treatment interruption

Safety and efficacy of VRC01 broadly neutralising antibodies in adults with acutely treated HIV (RV397): a phase 2, randomised, double-blind, placebo-controlled trial

Preferential Infection of α4β7+ Memory CD4+ T Cells During Early Acute Human Immunodeficiency Virus Type 1 Infection

The Thai phase III trial (RV144) vaccine regimen induces T cell responses that preferentially target epitopes within the V2 region of HIV-1 envelope

Impact of Early Antiretroviral Therapy on Detection of Cell-Associated HIV-1 Nucleic Acid in Blood by the Roche Cobas TaqMan Test

Suchergebnisse filtern